Showing results (571-580 of 794) with videos related to

Sort By:
Pageof 80
British Journal of Cancer|July 23, 2025
The colorectal liver metastasis growth pattern phenotype is not dependent on genotypeDiederik J Höppener, Sanne M L Verheul, Pieter M H Nierop, et al.
Nature Communications|November 6, 2024
Enhanced production of 60Fe in massive starsA Spyrou, D Richman, A Couture, et al.
The Lancet. Oncology|May 7, 2025
Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trialAlexandra Gilbert, Richard Adams, Joanne Webster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2021
Artificial Intelligence-Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal CancerChristopher J M Williams, Jenny F Seligmann, Faye Elliott, et al.
British Journal of Cancer|July 21, 2020
Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxiaStephanie G Craig, Matthew P Humphries, Matthew Alderdice, et al.
British Journal of Cancer|April 19, 2014
A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?T S Maughan, A M Meade, R A Adams, et al.
Oncotarget|October 4, 2017
Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancerLinda J W Bosch, Geert Trooskens, Petur Snaebjornsson, et al.
Plos Medicine|November 29, 2017
Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case studyNathan W Cummins, Stacey Rizza, Mark R Litzow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal CancerSudhir B Malla, David J Fisher, Enric Domingo, et al.
Annals of Internal Medicine|March 1, 1993
Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complexG Skowron, S A Bozzette, L Lim, et al.
Pageof 80